Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Artax Biopharma, Inc.

0001587661-26-000002 · filed May 5, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$19,000,000
Reported amount sold
$19,000,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Artax Biopharma, Inc.
CIK
1587661
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
ONE BROADWAY
CAMBRIDGE, Massachusetts 02142
Phone
617-368-0676

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗